Standard

Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference. / Masharipov, Ruslan; Knyazeva, Irina; Nikolaev, Yaroslav; Korotkov, Alexander; Didur, Michael; Cherednichenko, Denis; Kireev, Maxim.

In: Frontiers in Neuroinformatics, Vol. 15, 738342, 02.12.2021.

Research output: Contribution to journalArticlepeer-review

Harvard

Masharipov, R, Knyazeva, I, Nikolaev, Y, Korotkov, A, Didur, M, Cherednichenko, D & Kireev, M 2021, 'Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference', Frontiers in Neuroinformatics, vol. 15, 738342. https://doi.org/10.3389/fninf.2021.738342

APA

Masharipov, R., Knyazeva, I., Nikolaev, Y., Korotkov, A., Didur, M., Cherednichenko, D., & Kireev, M. (2021). Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference. Frontiers in Neuroinformatics, 15, [738342]. https://doi.org/10.3389/fninf.2021.738342

Vancouver

Masharipov R, Knyazeva I, Nikolaev Y, Korotkov A, Didur M, Cherednichenko D et al. Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference. Frontiers in Neuroinformatics. 2021 Dec 2;15. 738342. https://doi.org/10.3389/fninf.2021.738342

Author

Masharipov, Ruslan ; Knyazeva, Irina ; Nikolaev, Yaroslav ; Korotkov, Alexander ; Didur, Michael ; Cherednichenko, Denis ; Kireev, Maxim. / Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference. In: Frontiers in Neuroinformatics. 2021 ; Vol. 15.

BibTeX

@article{b6575f1e57fa47d09bc6095215dccc3c,
title = "Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference",
abstract = "Classical null hypothesis significance testing is limited to the rejection of the point-null hypothesis; it does not allow the interpretation of non-significant results. This leads to a bias against the null hypothesis. Herein, we discuss statistical approaches to {\textquoteleft}null effect{\textquoteright} assessment focusing on the Bayesian parameter inference (BPI). Although Bayesian methods have been theoretically elaborated and implemented in common neuroimaging software packages, they are not widely used for {\textquoteleft}null effect{\textquoteright} assessment. BPI considers the posterior probability of finding the effect within or outside the region of practical equivalence to the null value. It can be used to find both {\textquoteleft}activated/deactivated{\textquoteright} and {\textquoteleft}not activated{\textquoteright} voxels or to indicate that the obtained data are not sufficient using a single decision rule. It also allows to evaluate the data as the sample size increases and decide to stop the experiment if the obtained data are sufficient to make a confident inference. To demonstrate the advantages of using BPI for fMRI data group analysis, we compare it with classical null hypothesis significance testing on empirical data. We also use simulated data to show how BPI performs under different effect sizes, noise levels, noise distributions and sample sizes. Finally, we consider the problem of defining the region of practical equivalence for BPI and discuss possible applications of BPI in fMRI studies. To facilitate {\textquoteleft}null effect{\textquoteright} assessment for fMRI practitioners, we provide Statistical Parametric Mapping 12 based toolbox for Bayesian inference.",
keywords = "Bayesian analyses, fMRI, human brain, null results, statistical parametric mapping",
author = "Ruslan Masharipov and Irina Knyazeva and Yaroslav Nikolaev and Alexander Korotkov and Michael Didur and Denis Cherednichenko and Maxim Kireev",
note = "Publisher Copyright: Copyright {\textcopyright} 2021 Masharipov, Knyazeva, Nikolaev, Korotkov, Didur, Cherednichenko and Kireev.",
year = "2021",
month = dec,
day = "2",
doi = "10.3389/fninf.2021.738342",
language = "English",
volume = "15",
journal = "Frontiers in Neuroinformatics",
issn = "1662-5196",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Providing Evidence for the Null Hypothesis in Functional Magnetic Resonance Imaging Using Group-Level Bayesian Inference

AU - Masharipov, Ruslan

AU - Knyazeva, Irina

AU - Nikolaev, Yaroslav

AU - Korotkov, Alexander

AU - Didur, Michael

AU - Cherednichenko, Denis

AU - Kireev, Maxim

N1 - Publisher Copyright: Copyright © 2021 Masharipov, Knyazeva, Nikolaev, Korotkov, Didur, Cherednichenko and Kireev.

PY - 2021/12/2

Y1 - 2021/12/2

N2 - Classical null hypothesis significance testing is limited to the rejection of the point-null hypothesis; it does not allow the interpretation of non-significant results. This leads to a bias against the null hypothesis. Herein, we discuss statistical approaches to ‘null effect’ assessment focusing on the Bayesian parameter inference (BPI). Although Bayesian methods have been theoretically elaborated and implemented in common neuroimaging software packages, they are not widely used for ‘null effect’ assessment. BPI considers the posterior probability of finding the effect within or outside the region of practical equivalence to the null value. It can be used to find both ‘activated/deactivated’ and ‘not activated’ voxels or to indicate that the obtained data are not sufficient using a single decision rule. It also allows to evaluate the data as the sample size increases and decide to stop the experiment if the obtained data are sufficient to make a confident inference. To demonstrate the advantages of using BPI for fMRI data group analysis, we compare it with classical null hypothesis significance testing on empirical data. We also use simulated data to show how BPI performs under different effect sizes, noise levels, noise distributions and sample sizes. Finally, we consider the problem of defining the region of practical equivalence for BPI and discuss possible applications of BPI in fMRI studies. To facilitate ‘null effect’ assessment for fMRI practitioners, we provide Statistical Parametric Mapping 12 based toolbox for Bayesian inference.

AB - Classical null hypothesis significance testing is limited to the rejection of the point-null hypothesis; it does not allow the interpretation of non-significant results. This leads to a bias against the null hypothesis. Herein, we discuss statistical approaches to ‘null effect’ assessment focusing on the Bayesian parameter inference (BPI). Although Bayesian methods have been theoretically elaborated and implemented in common neuroimaging software packages, they are not widely used for ‘null effect’ assessment. BPI considers the posterior probability of finding the effect within or outside the region of practical equivalence to the null value. It can be used to find both ‘activated/deactivated’ and ‘not activated’ voxels or to indicate that the obtained data are not sufficient using a single decision rule. It also allows to evaluate the data as the sample size increases and decide to stop the experiment if the obtained data are sufficient to make a confident inference. To demonstrate the advantages of using BPI for fMRI data group analysis, we compare it with classical null hypothesis significance testing on empirical data. We also use simulated data to show how BPI performs under different effect sizes, noise levels, noise distributions and sample sizes. Finally, we consider the problem of defining the region of practical equivalence for BPI and discuss possible applications of BPI in fMRI studies. To facilitate ‘null effect’ assessment for fMRI practitioners, we provide Statistical Parametric Mapping 12 based toolbox for Bayesian inference.

KW - Bayesian analyses

KW - fMRI

KW - human brain

KW - null results

KW - statistical parametric mapping

UR - http://www.scopus.com/inward/record.url?scp=85121454706&partnerID=8YFLogxK

U2 - 10.3389/fninf.2021.738342

DO - 10.3389/fninf.2021.738342

M3 - Article

AN - SCOPUS:85121454706

VL - 15

JO - Frontiers in Neuroinformatics

JF - Frontiers in Neuroinformatics

SN - 1662-5196

M1 - 738342

ER -

ID: 92287421